Literature DB >> 11944989

An integrated, functionally annotated gene map of the DXS8026-ELK1 interval on human Xp11.3-Xp11.23: potential hotspot for neurogenetic disorders.

Dawn L Thiselton1, Jennifer McDowall, Oliver Brandau, Juliane Ramser, Fabiana d'Esposito, Shomi S Bhattacharya, Mark T Ross, Alison J Hardcastle, Alfons Meindl.   

Abstract

Human chromosome Xp11.3-Xp11.23 encompasses the map location for a growing number of diseases with a genetic basis or genetic component. These include several eye disorders, syndromic and nonsyndromic forms of X-linked mental retardation (XLMR), X-linked neuromuscular diseases and susceptibility loci for schizophrenia, type 1 diabetes, and Graves' disease. We have constructed an approximately 2.7-Mb high-resolution physical map extending from DXS8026 to ELK1, corresponding to a genetic distance of approximately 5.5 cM. A combination of chromosome walking and sequence-tagged site (STS)-content mapping resulted in an integrated framework and transcript map, precisely positioning 10 polymorphic microsatellites (one of which is novel), 16 ESTs, and 12 known genes (RP2, PCTK1, UHX1, UBE1, RBM10, ZNF157, SYN1, ARAF1, TIMP1, PFC, ELK1, UXT). The composite map is currently anchored with 89 STSs to give an average resolution of approximately 1 STS every 30 kb. By a combination of EST database searches and in silico detection of UniGene clusters within genomic sequence generated from this template map, we have mapped several novel genes within this interval: a Na+/H+ exchanger (SLC9A7), at least two zincfinger transcription factors (KIAA0215 and Hs.68318), carbohydrate sulfotransferase-7 (CHST7), regucalcin (RGN), inactivation-escape-1 (INE1), the human ortholog of mouse neuronal protein 15.6, and four putative novel genes. Further genomic analysis enabled annotation of the sequence interval with 20 predicted pseudogenes and 21 UniGene clusters of unknown function. The combined PAC/BAC transcript map and YAC scaffold presented here clarifies previously conflicting data for markers and genes within the Xp11.3-Xp11.23 interval and provides a powerful integrated resource for functional characterization of this clonally unstable, yet gene-rich and clinically significant region of proximal Xp.

Entities:  

Mesh:

Year:  2002        PMID: 11944989     DOI: 10.1006/geno.2002.6733

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  29 in total

1.  Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate.

Authors:  Jennifer J Johnston; Jamie K Teer; Praveen F Cherukuri; Nancy F Hansen; Stacie K Loftus; Karen Chong; James C Mullikin; Leslie G Biesecker
Journal:  Am J Hum Genet       Date:  2010-05-06       Impact factor: 11.025

Review 2.  Regucalcin and metabolic disorders: osteoporosis and hyperlipidemia are induced in regucalcin transgenic rats.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2010-03-28       Impact factor: 3.396

3.  The transcriptional regulation of regucalcin gene expression.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2010-10-11       Impact factor: 3.396

Review 4.  Regucalcin and cell regulation: role as a suppressor protein in signal transduction.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2011-03-24       Impact factor: 3.396

Review 5.  Novel protein RGPR-p117: its role as the regucalcin gene transcription factor.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2009-02-12       Impact factor: 3.396

6.  Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy.

Authors:  Juliane Ramser; Mary Ellen Ahearn; Claus Lenski; Kemal O Yariz; Heide Hellebrand; Michael von Rhein; Robin D Clark; Rita K Schmutzler; Peter Lichtner; Eric P Hoffman; Alfons Meindl; Lisa Baumbach-Reardon
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

7.  UXT (Ubiquitously Expressed Transcript) causes mitochondrial aggregation.

Authors:  Tijuana N Moss; Amy Vo; Wallace L McKeehan; Leyuan Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-03-21       Impact factor: 2.416

Review 8.  Regucalcin as a potential biomarker for metabolic and neuronal diseases.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2014-03-06       Impact factor: 3.396

Review 9.  Suppressive role of regucalcin in liver cell proliferation: involvement in carcinogenesis.

Authors:  M Yamaguchi
Journal:  Cell Prolif       Date:  2013-06       Impact factor: 6.831

10.  A recurrent missense variant in SLC9A7 causes nonsyndromic X-linked intellectual disability with alteration of Golgi acidification and aberrant glycosylation.

Authors:  Wujood Khayat; Anna Hackett; Marie Shaw; Alina Ilie; Tracy Dudding-Byth; Vera M Kalscheuer; Louise Christie; Mark A Corbett; Jane Juusola; Kathryn L Friend; Brian M Kirmse; Jozef Gecz; Michael Field; John Orlowski
Journal:  Hum Mol Genet       Date:  2019-02-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.